Impact on mortality of being seropositive for hepatitis C virus antibodies among blood donors in Brazil: A twenty-year study.
Hélio Ranes de Menezes FilhoAna Luiza de Souza BierrenbachMaria Ligia Damato CapuaniAlfredo MendroneAdele Schwartz BenzakenSoraia Mafra MachadoMarielena Vogel SaivishEster Cerdeira SabinoSteven Sol WitkinMaria Cássia Mendes-CorreaPublished in: PloS one (2019)
All-cause and liver-related mortality rate was increased among blood donors seropositive for HCV compared with the mortality rate among seronegative blood donors. Our data confirms HCV as a relevant cause of death in Brazil and also suggest that interventions directed at following patients even after access to specific drug treatment are urgent and necessary.
Keyphrases
- hepatitis c virus
- cardiovascular events
- human immunodeficiency virus
- end stage renal disease
- chronic kidney disease
- risk factors
- ejection fraction
- physical activity
- emergency department
- prognostic factors
- patient reported outcomes
- big data
- cardiovascular disease
- coronary artery disease
- electronic health record
- hiv infected
- deep learning
- antiretroviral therapy
- patient reported